THE DETERMINANTS OF INNOVATIVE DRUGS PRICES: THE CASE OF ONCOLOGY DRUGS, COMPARATIVE ANALYSIS

被引：0
|
作者：
Aissaoui, A. [1 ]
Levy, P. [2 ]
机构：
[1] Univ Paris 09, PSL, Paris, France
[2] Univ Paris 09, Paris, France
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.022
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PR4
引用
收藏
页码：A350 / A350
页数：1
相关论文
共 50 条
  • [1] Determinants of orphan drugs prices in France: a regression analysis
    Korchagina, Daria
    Millier, Aurelie
    Vataire, Anne-Lise
    Aballea, Samuel
    Falissard, Bruno
    Toumi, Mondher
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [2] Determinants of orphan drugs prices in France: a regression analysis
    Daria Korchagina
    Aurelie Millier
    Anne-Lise Vataire
    Samuel Aballea
    Bruno Falissard
    Mondher Toumi
    Orphanet Journal of Rare Diseases, 12
  • [3] CONTINENTAL COMPARISON OF INNOVATIVE DRUGS PRICES, THE CASE OF ONCOLOGY USED FOR TREATMENT OF SOLID TUMORS IN GERMANY AND THE UNITED STATES
    Aissaoui, N.
    Bin Sawad, A.
    Turkistani, F.
    VALUE IN HEALTH, 2016, 19 (07) : A758 - A758
  • [4] DETERMINANTS OF THE PRICES OF ORPHAN DRUGS IN FRANCE
    Lanecka, A. .
    Aballea, S.
    Reguei, I.
    Belgaied, W.
    Toumi, M.
    VALUE IN HEALTH, 2024, 27 (12)
  • [5] Drug Prices and Value of Oncology Drugs in Italy
    Russo, Pierluigi
    Marcellusi, Andrea
    Zanuzzi, Matteo
    Carletto, Angelica
    Fratto, Maria Elisabetta
    Favato, Giampiero
    Staniscia, Tommaso
    Romano, Ferdinando
    VALUE IN HEALTH, 2021, 24 (09) : 1273 - 1278
  • [6] Current prices of innovative drugs are too high
    Ludwig, W. -D
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 114 - 114
  • [7] Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
    Pauwels, Kim
    Huys, Isabelle
    Casteels, Minne
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [8] DETERMINANTS OF NATIONAL REIMBURSEMENT FOR NEW ONCOLOGY DRUGS: A RETROSPECTIVE ANALYSIS IN TAIWAN
    Lin, Y.
    Liao, K.
    Hsiao, F.
    VALUE IN HEALTH, 2018, 21 : S21 - S21
  • [9] CANCER DRUGS IN GERMANY: HTA DECISIONS OF NEW AND INNOVATIVE ONCOLOGY DRUGS IN GERMANY - AN ANALYSIS USING THE PRISMACCESS® DATABASE
    Mayer, F.
    Hodek, J.
    Walzer, S.
    VALUE IN HEALTH, 2018, 21 : S63 - S64
  • [10] Innovative oncology Drugs: Explosive device targeted for the Solidarity?
    Glossmann, J-P.
    Walshe, R.
    Bernschein, A.
    Hallek, M.
    Wolf, J.
    ONKOLOGIE, 2010, 33 : 51 - 51
12345